Ausgabe 8/2011
Inhalt (6 Artikel)
In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development
Olavi Pelkonen, Miia Turpeinen, Hannu Raunio
A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and Neonates
Friederike Traunmüller, Martin Popovic, Karl-Heinz Konz, Patrick Vavken, Andreas Leithner, Christian Joukhadar
Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data
An Van den Bergh, Vikash Sinha, Ron Gilissen, Roel Straetemans, Koen Wuyts, Denise Morrison, Luc Bijnens, Claire Mackie
Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions
Michel Tod, Sylvain Goutelle, Fannie Clavel-Grabit, Grégoire Nicolas, Bruno Charpiat
HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz than Healthy Subjects
Jackson K. Mukonzo, Sarah Nanzigu, Dinko Rekić, Paul Waako, Daniel Röshammar, Michael Ashton, Jasper Ogwal-Okeng, Lars L. Gustafsson, Eleni Aklillu
Randomized, Open-Label, Multicentre Pharmacokinetic Studies of Two Dose Levels of Pantoprazole Granules in Infants and Children Aged 1 Month through <6 Years with Gastro-Oesophageal Reflux Disease
Brinda K. Tammara, Janice E. Sullivan, Kim G. Adcock, Jaroslaw Kierkus, John Giblin, Natalie Rath, Xu Meng, Mary K. Maguire, Gail M. Comer, Robert M. Ward